Pluripotent Stem Cell Hepatocyte Differentiation via Collagen Gel
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for evaluating hepatotoxicity, such as in vivo animal tests and human primary hepatocyte assays, face challenges like species differences, limited supply of primary hepatocytes, and rapid decline in drug-metabolizing enzyme activity, necessitating a more effective way to obtain mature hepatocytes for drug testing.
Innovation Solution
A method involving the differentiation of pluripotent stem cells into hepatocytes using a culture medium with specific growth factors and culturing on a high-density collagen gel membrane, specifically using activin A, BMP4, FGF10, HGF, and oncostatin M, to achieve highly matured hepatocytes with elevated CYP3A4 expression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If human primary hepatocytes are used for hepatotoxicity evaluation, then accuracy of human liver toxicity assessment is improved, but supply limitation and lot-difference problems occur
Solution Approach 1:
The invention creates a copy of primary hepatocytes by differentiating pluripotent stem cells into hepatocytes that replicate the functional characteristics, metabolic enzyme activities, and transporter expressions of primary hepatocytes, thereby providing an unlimited supply while maintaining evaluation accuracy
Solution Approach 2:
The invention changes the source parameter from primary hepatocytes to differentiated hepatocytes from pluripotent stem cells, while optimizing culture conditions including collagen gel concentration (1.5-3.0 mg/mL), growth factor combinations, and culture duration to achieve comparable functional parameters
2Ease of operation
If human primary hepatocytes are cultured, then hepatotoxicity testing can be performed, but drug-metabolizing enzyme activity decreases rapidly
Solution Approach 1:
The differentiated hepatocytes from pluripotent stem cells copy the metabolic functionality of primary hepatocytes but maintain enzyme activity stability for extended periods (at least 14 days), overcoming the rapid decline observed in primary hepatocytes
Solution Approach 2:
The invention performs preliminary differentiation of pluripotent stem cells into mature hepatocytes with fully developed metabolic enzyme systems before use in toxicology assays, ensuring optimal enzyme activity from the start of experiments
3Productivity
If pluripotent stem cells are differentiated into hepatocytes using conventional methods, then hepatocyte production is achieved, but maturation level and enzyme expression are insufficient
Solution Approach 1:
The invention optimizes multiple parameters including collagen gel concentration (1.5-3.0 mg/mL), growth factor dosages and combinations, culture duration (21-42 days), and oxygen tension to achieve high maturation levels with CYP3A4 expression reaching 2-10% of primary hepatocyte levels
Solution Approach 2:
The invention uses a composite culture system combining collagen gel matrix with specific growth factors (HGF, OSM, BMP4, FGF10) and activators to create an optimized differentiation environment that promotes mature hepatocyte phenotypes
Data Source
AI summary
The present invention provides, in order to prepare matured hepatocytes analogous in various points to primary hepatocytes, a method for preparing hepatocytes or cells that can be differentiated into hepatocytes from pluripotent stem cells, comprising the steps of: (1) culturing the pluripotent stem cells in a medium containing an activator of an activin receptor-like kinase-4,7; (2) culturing the cells obtained in the step (1) in a medium containing a bone morphogenetic factor and a fibroblast growth factor; (3) culturing the cells obtained in the step (2) in a medium containing an activator of a hepatocyte growth factor receptor and an activator of an oncostatin M receptor; and (4) culturing the cells obtained in the step (3) to obtain hepatocytes or cells that can be differentiated into hepatocytes, wherein in at least one of the steps (2), (3) and (4), cells are cultured on a high-density collagen gel membrane.